Priya Singhal - Feb 10, 2025 Form 4 Insider Report for BIOGEN INC. (BIIB)

Role
Head of Development
Signature
/s/ Samuel Ntonme, attorney-in-fact for Priya Singhal
Stock symbol
BIIB
Transactions as of
Feb 10, 2025
Transactions value $
-$50,887
Form type
4
Date filed
2/12/2025, 05:48 PM
Previous filing
Feb 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIIB Common Stock Options Exercise $0 +1.21K +14.76% $0.00 9.42K Feb 10, 2025 Direct
transaction BIIB Common Stock Tax liability -$50.9K -357 -3.79% $142.54 9.07K Feb 10, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIIB Restricted Stock Unit Options Exercise $0 -1.21K -100% $0.00 0 Feb 10, 2025 Common Stock 1.21K $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award was granted to the reporting person on February 10, 2022 and will vest in three equal installments on each anniversary of the grant date.